The Efficacy of a Cosmetic Preparation Containing Sheep Colostrum on Mature Skin
NCT ID: NCT06305923
Last Updated: 2024-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2022-03-01
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will be enrolled to the colostrum cream or base cream groups and will not be informed which group they belonged to.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365
NCT07208227
Assessment of the Efficacy and Barrier Protection of Two Cosmetic Products
NCT03629405
Tolerability and Efficacy of Anti-Aging Treatment Regimen in Subjects With Photodamage
NCT02422836
Macrolane for Enhancement of the Shape and Fullness of the Female Breast
NCT01308853
Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product
NCT05300984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be given the creams and will be asked to apply one -two doses in the evening after nighttime facial cleaning. They will be also asked to use sunscreens during the day.
1. Instrumental Measurements of Skin Parameters During the first visit and after eight weeks of everyday use of the tested cream, the skin parameters will be measured three times on both cheeks, and the results will be averaged.
The skin will be measured at standardized temperature and humidity using a Courage + Khazaka electronic GmbH Multi Probe Adapter with the use of the following probes:
* Corneometer® CM825 probe: measuring skin hydration based on water content in the stratum corneum;
* Tewameter® TM probe: assessing transepidermal water loss;
* Mexameter® MX18 probe: measuring the level of hemoglobin (erythema) and mel-anin, the two main dyes responsible for skin color;
* Sebumeter® SM 815 probe: measuring skin sebum level, independent of water con-tent;
* Cutometer® MPA 580 probe: measuring the viscoelastic properties of the skin. The R0 and F0 parameters were chosen. R0 represents the passive response of the skin to force, lower values indicate greater firmness. F0 - firmness of the skin at the time of suction. Lower values indicate more elastic skin.
2. Photodocumentation The skin will be subjected to photodocumentation at the first and last visit with the use of the Photomedicus system. The photos will be taken in standard light and with stand-ardized face positions. The photos will be compared using the following scale: 0 means no improvement (the same as the initial picture), 1 - slight improvement, 2 - moderate improvement, 3 - marked improvement (marked improvement in appearance from the initial condition, but not completely optimal), 4 - greatest possible improvement (optimal aesthetic result).
3. Subjective assessment of the skin All participants, i.e. in both groups, subjectively will assess their skin condition after eight weeks of treatment. Participants will rate smoothing of shallow wrinkles, skin tone alignment, regeneration, hydration, elasticity, softness, redness reduction and hypersen-sitivity reduction; they will indicate either improvement, deterioration or no change. Finally, the results in each group will be presented as the percentage of subjects with improved, worsened or unchanged skin.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo cream
everyday using of placebo cream
placebo cream
using a placebo cream
colostrum cream
everyday using of colostrum cream
colostrum cream
the intervention in our study is everyday using a cream with active ingridient
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
colostrum cream
the intervention in our study is everyday using a cream with active ingridient
placebo cream
using a placebo cream
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent
Exclusion Criteria
* Allergic to milk proteins
* Suffer from neoplasms, contagious infections, autoimmunologic diseases
* Suffer from face skin diseases
* Have had an aesthetic procedure on the skin of the face during the last two months
* Have been treated with isotretinoin or other oral retinoids during the last six months
40 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Lodz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Lodz
Lodz, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
503/3-066-02/503-31-001
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
RNN/275/21/KE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.